Staff Report
The global magnetic resonance imaging (MRI) market is experiencing significant growth, driven by technological advancements, an aging population, and the increasing prevalence of chronic diseases. Valued at $7.1 billion in 2024, the market is projected to reach $10.29 billion by 2030, growing at a compound annual growth rate (CAGR) of 6.5%, according to Grand View Research.
Technological innovations are central to this expansion. Recent developments include the integration of artificial intelligence (AI) in MRI systems, enhancing image reconstruction and diagnostic accuracy. For instance, in August 2023, FUJIFILM Healthcare Americas Corporation received U.S. FDA clearance for its 1.5 Tesla MRI system, the ECHELON Synergy, which utilizes Synergy DLR, a deep learning reconstruction technology that improves image sharpness and accelerates scanning.
The market is also witnessing a shift in MRI system architecture preferences. Closed MRI systems held the largest share of over 75% in 2023 due to their superior image quality. However, open MRI systems are gaining traction, especially among claustrophobic patients and pediatric cases, and are expected to grow at a CAGR of 7.7% during the forecast period.
Field strength is another critical factor influencing the market. Mid-field MRI systems (1.5T to 3T) accounted for 47.7% of the market share in 2023, favored for their balance between image quality and cost. High-field MRI systems (>3T) are anticipated to experience the fastest growth rate of 7.9%, driven by their enhanced imaging capabilities, particularly in neurological and musculoskeletal applications.
The rising prevalence of chronic diseases such as cancer, cardiovascular disorders, and neurological conditions is a significant driver of MRI market growth. According to the International Agency for Research on Cancer, over 19.2 million new cancer cases were recorded globally in 2020. MRI plays a crucial role in the early detection and monitoring of these diseases, thereby increasing its demand, according to Grand View Research.
Regionally, North America dominated the global MRI market with a share of over 36.74% in 2023, attributed to the high prevalence of chronic diseases and advanced healthcare infrastructure. Asia Pacific is expected to exhibit the fastest growth rate of 7.4% during the forecast period, driven by an increasing geriatric population, rising healthcare expenditures, and growing medical tourism in countries like India, China, and Japan, according to Grand View Research
MarketsandMarkets and Grand View Research agree that despite the positive outlook, the MRI market faces challenges such as the high cost of MRI systems, which can range from $1 million to $5 million depending on the system’s features and field strength. Additionally, the shortage of trained professionals to operate advanced MRI systems poses a barrier to adoption in some regions.
Key players in the MRI market include Siemens Healthineers, GE Healthcare, Koninklijke Philips N.V., and Canon Medical Systems. These companies are investing in research and development to introduce innovative technologies that enhance imaging quality and patient comfort.
In conclusion, the global MRI market is poised for substantial growth, driven by technological advancements, an aging population, and the increasing prevalence of chronic diseases. While challenges such as high equipment costs and a shortage of trained professionals persist, the integration of AI and the development of more patient-friendly MRI systems present significant opportunities for market expansion.
